Synergic Medical Technologies, Inc.
Develops non-invasive neuromodulation approaches targeting Parkinson’s disease. Conducts research into how Parkinson’s disease alters brain activity and how non-invasive neuromodulation techniques can restore specific brain functions and relieve symptoms. Engaged with regulatory authorities as evidenced by a Breakthrough Device designation.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Non-invasive neuromodulation device for Parkinson’s disease
A medical device under development intended to non-invasively modulate brain activity to address motor and non-motor symptoms of Parkinson’s disease. Specific product name and technical specifications were not provided on the source pages.
Non-invasive neuromodulation device for Parkinson’s disease
A medical device under development intended to non-invasively modulate brain activity to address motor and non-motor symptoms of Parkinson’s disease. Specific product name and technical specifications were not provided on the source pages.
Expertise Areas
- Non-invasive neuromodulation
- Parkinson’s disease research
- Clinical research for neuromodulation devices
- Regulatory strategy and engagement for medical devices
Key Technologies
- Non-invasive neuromodulation
- Neurophysiological monitoring and brain activity analysis
- Medical device development
- Clinical assessment workflows
News & Updates
Company newsletter with recent announcements (February 2025).
The company received a Breakthrough Device designation from the U.S. Food and Drug Administration for a neuromodulation device intended for Parkinson’s disease.
Company newsletter with recent announcements (February 2025).
The company received a Breakthrough Device designation from the U.S. Food and Drug Administration for a neuromodulation device intended for Parkinson’s disease.